Literature DB >> 2052358

c-myc protein expression in untransformed fibroblasts.

C M Waters1, T D Littlewood, D C Hancock, J P Moore, G I Evan.   

Abstract

We have examined and quantitated the expression of c-myc protein in two untransformed fibroblast cell lines, murine Swiss 3T3 and human MRC-5, c-myc protein is not detectable in quiescent cells, but it is rapidly induced upon mitogenic stimulation. Peak expression is seen about 3-5 h after serum stimulation, and corresponds to about 3-6000 molecules per cell (mpc). Thereafter, levels fall back to a quiescent level in confluent fibroblasts, but remain elevated at 1-3000 mpc in subconfluent cells. The c-myc protein is phosphorylated and has the same size and short half-life as seen in tumour cells. Removal of serum growth factors from the culture medium causes very rapid loss of the c-myc protein from all cells, irrespective of their positions in the cell cycle. Thus, c-myc expression is continuously dependent upon the presence of mitogens. However, no single tested mitogen is obligatory for maintenance of expression in proliferating cells. Growth arrest of cells, either by metabolite starvation or by drugs which inhibit DNA synthesis, does not affect expression of the c-myc protein, which remains completely dependent upon the presence of mitogens. These data are consistent with the c-myc protein's having a continuous role in proliferating cells as an intracellular integrator of growth regulatory signalling pathways.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052358

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  42 in total

1.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.

Authors:  S Mai; J Hanley-Hyde; G J Rainey; T I Kuschak; J T Paul; T D Littlewood; H Mischak; L M Stevens; D W Henderson; J F Mushinski
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

3.  Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1.

Authors:  Brian M Iritani; Jeffrey Delrow; Carla Grandori; Ivan Gomez; Meredith Klacking; Leni Sue Carlos; Robert N Eisenman
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

4.  Molecular dissection of telomeric repeat-containing RNA biogenesis unveils the presence of distinct and multiple regulatory pathways.

Authors:  Antonio Porro; Sascha Feuerhahn; Patrick Reichenbach; Joachim Lingner
Journal:  Mol Cell Biol       Date:  2010-08-16       Impact factor: 4.272

Review 5.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

6.  Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins.

Authors:  Wei-Jian Guo; Sonal Datta; Vimla Band; Goberdhan P Dimri
Journal:  Mol Biol Cell       Date:  2006-12-06       Impact factor: 4.138

7.  The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression.

Authors:  Juhong Liu; Fedor Kouzine; Zuqin Nie; Hye-Jung Chung; Zichrini Elisha-Feil; Achim Weber; Keji Zhao; David Levens
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

8.  FBPs are calibrated molecular tools to adjust gene expression.

Authors:  Hye-Jung Chung; Juhong Liu; Miroslav Dundr; Zuqin Nie; Suzanne Sanford; David Levens
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

9.  The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene.

Authors:  Ling Lin; Jian-Hua Zhang; Leelamma M Panicker; William F Simonds
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

10.  Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.

Authors:  Paula L Miliani de Marval; Everardo Macias; Robert Rounbehler; Piotr Sicinski; Hiroaki Kiyokawa; David G Johnson; Claudio J Conti; Marcelo L Rodriguez-Puebla
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.